JP2018058789A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018058789A5 JP2018058789A5 JP2016197206A JP2016197206A JP2018058789A5 JP 2018058789 A5 JP2018058789 A5 JP 2018058789A5 JP 2016197206 A JP2016197206 A JP 2016197206A JP 2016197206 A JP2016197206 A JP 2016197206A JP 2018058789 A5 JP2018058789 A5 JP 2018058789A5
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- wound healing
- protamine
- pharmaceutically acceptable
- wound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016197206A JP6456897B2 (ja) | 2016-10-05 | 2016-10-05 | 抗菌性及び創傷治癒促進性を有する創傷治癒剤 |
| PCT/JP2017/036060 WO2018066580A1 (ja) | 2016-10-05 | 2017-10-04 | 抗菌性及び創傷治癒促進性を有する創傷治癒剤 |
| CN201780061936.7A CN109803726A (zh) | 2016-10-05 | 2017-10-04 | 具有抗菌性及促进创伤治愈性的创伤治愈剂 |
| EP17858417.3A EP3524323A4 (en) | 2016-10-05 | 2017-10-04 | Wound healing agent with activity to promote anti-bacterial properties and wound healing properties |
| US16/339,342 US20200038479A1 (en) | 2016-10-05 | 2017-10-04 | Wound healing agent having antimicrobial activity and wound healing accelerating activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016197206A JP6456897B2 (ja) | 2016-10-05 | 2016-10-05 | 抗菌性及び創傷治癒促進性を有する創傷治癒剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018058789A JP2018058789A (ja) | 2018-04-12 |
| JP2018058789A5 true JP2018058789A5 (enExample) | 2018-07-26 |
| JP6456897B2 JP6456897B2 (ja) | 2019-01-23 |
Family
ID=61831414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016197206A Expired - Fee Related JP6456897B2 (ja) | 2016-10-05 | 2016-10-05 | 抗菌性及び創傷治癒促進性を有する創傷治癒剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20200038479A1 (enExample) |
| EP (1) | EP3524323A4 (enExample) |
| JP (1) | JP6456897B2 (enExample) |
| CN (1) | CN109803726A (enExample) |
| WO (1) | WO2018066580A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102283464B1 (ko) * | 2019-06-28 | 2021-08-02 | 경북대학교 산학협력단 | Vegf 펩타이드를 포함하는 하이드로겔 기반 창상 피복재 및 이의 제조방법 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0720873B2 (ja) | 1984-11-29 | 1995-03-08 | キュラテック・インコ−ポレ−テッド | 創傷治癒剤 |
| JPS61253065A (ja) * | 1985-05-02 | 1986-11-10 | 片倉チツカリン株式会社 | キトサン誘導体およびコラ−ゲンの複合材の医用材料およびその製造法 |
| US5861149A (en) | 1997-06-04 | 1999-01-19 | Polyheal Ltd. | Methods for wound treatment |
| US20080139450A1 (en) * | 2005-07-01 | 2008-06-12 | Srinivasa Madhyastha | Antimicrobial Compositions and Uses Thereof |
| GB0525504D0 (en) | 2005-12-14 | 2006-01-25 | Bristol Myers Squibb Co | Antimicrobial composition |
| EP2389071B1 (en) | 2009-01-23 | 2017-08-30 | Kane Biotech Inc. | Biofilm-removing antimicrobial compositions and uses thereof |
| EP2412795B1 (en) * | 2009-03-27 | 2016-12-28 | Maruha Nichiro Corporation | Crosslinked material comprising elastin and collagen, and use thereof |
| EP3010524B1 (en) * | 2013-06-18 | 2019-12-25 | University of Helsinki | Protamine in treatment of neuronal injuries |
| WO2016076744A1 (ru) * | 2014-11-13 | 2016-05-19 | Борис Славинович ФАРБЕР | Фармацевтическая композиция с гемостатическим и ранозаживляющим действием |
-
2016
- 2016-10-05 JP JP2016197206A patent/JP6456897B2/ja not_active Expired - Fee Related
-
2017
- 2017-10-04 CN CN201780061936.7A patent/CN109803726A/zh not_active Withdrawn
- 2017-10-04 US US16/339,342 patent/US20200038479A1/en not_active Abandoned
- 2017-10-04 WO PCT/JP2017/036060 patent/WO2018066580A1/ja not_active Ceased
- 2017-10-04 EP EP17858417.3A patent/EP3524323A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024010140A (es) | Nuevos metodos. | |
| IL268850A (en) | Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases | |
| JP2016518337A5 (enExample) | ||
| WO2016113550A3 (en) | Dressing | |
| AR099354A1 (es) | Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos | |
| WO2014205389A8 (en) | Nuclear transport modulators and uses thereof | |
| WO2017091739A8 (en) | Topical film-forming spray | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| WO2015077503A8 (en) | Autotaxin inhibitor compounds | |
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| HUE052332T2 (hu) | Heteroaril-származék vagy gyógyászatilag elfogadható sója, eljárás annak elõállítására, és az ezeket hatóanyagént tartalmazó gyógyászati készítmény PI3 kinázokkal összefüggõ betegségek megelõzésére vagy kezelésére | |
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| MX374944B (es) | Derivado de piranocromenil fenol, y composición farmacéutica para tratar un síndrome metabólico o enfermedad inflamatoria. | |
| HK1223304A1 (zh) | 包含二甲双胍和二氢槲皮素的药物组合及其用於治疗癌症的用途 | |
| JP2013538853A5 (enExample) | ||
| FI3248597T3 (fi) | Terapeuttinen aine sensorineuraaliseen kuulonmenetykseen | |
| CA3010568A1 (en) | Oromucosal nanofiber carriers for therapeutic treatment | |
| UY37671A (es) | N-ariletil-2-aminoquinolin-4-carboxamidas sustituidas y su uso | |
| WO2013092457A3 (de) | Wirkstoffkombinationen aus einer oder mehreren carbonsäuren, insbesondere hydroxycarbonsäuren, und einer oder mehreren physiologisch unbedenklichen hydroxamsäure sowie kosmetische oder dermatologische zubereitungen, solche wirkstoffkombinationen enthaltend | |
| JP2017513944A5 (enExample) | ||
| JP2018058789A5 (enExample) | ||
| JP2016175884A5 (enExample) | ||
| MX381932B (es) | Composicion intranasal que comprende betahistina. | |
| ZA201905309B (en) | Pharmaceutical active ingredient and use thereof, in particular for the prevention and treatment of metabolic disorders in humans and animals | |
| JP2017513945A5 (enExample) |